Koglo
Home Device for Fluid Therapy for Cats and Dogs
Company Overview
Snapshot
Founded in January 2018 by Yotam Kaufman, Gilad Lavi, Shlomo Amiel, and Gilad Segev, Koglo operated with 1–10 employees. The company secured funding from Nir Zohar across 1 funding round. Koglo ceased operations in August 2024.
Business overview
Koglo developed EZXS, a home-use device designed to simplify and reduce the stress associated with administering subcutaneous treatments to cats and dogs. The technology focuses on maximizing pet safety and minimizing owner stress during the procedure, featuring a hidden needle and a safety mechanism to prevent injuries. Koglo operates within the Health Tech & Life Sciences sector, specifically targeting the medical devices industry and pet owners with its home care solutions for veterinary treatments.
Log in to access full profile ›Company Intelligence Q&A
- What is Koglo's primary product?
- Koglo's primary product is EZXS, a home device designed for fluid therapy for cats and dogs, aiming to simplify subcutaneous treatments.
- When was Koglo founded?
- Koglo was founded in January 2018.
- Who are the founders of Koglo?
- The founders of Koglo are Yotam Kaufman, Gilad Lavi, Shlomo Amiel, and Gilad Segev.
- In which sector does Koglo primarily operate?
- Koglo primarily operates in the Health Tech & Life Sciences sector, focusing on medical devices and home care for pets.
- What is the current operational status of Koglo?
- Koglo ceased to operate in August 2024.